🇺🇸 SECHaleon plcCodex · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 19:51:06·⟳ 抓取 19:51:30 +24s·⚡ 决策 09-01 21:45:54 +1h54m·55.9 天前
Haleon披露截至8月31日总投票权和股本，属例行持股申报基数更新
该6-K为例行月度总投票权和股本披露，用于权益通知计算，不改变公司每股经济权益、现金流、经营预期或可交易催化。
📄 原文Haleon plc↗ 原文
----- a6350s.htm ----- 6-K 1 a6350s.htm TOTAL VOTING RIGHTS AND CAPITAL a6350s UNITED STATES SECURITIES AND EXCHANGE CO…
不做 Haleon plc（HLN.US）
例行总投票权和股本披露，无经营、业绩、资本配置或控制权增量，缺乏可交易edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
原文只披露Haleon截至2026年8月31日的已发行股本、库存股和有投票权股份数，属于英国上市公司常规DTR申报基数更新；没有新增订单、业绩、资本返还、融资稀释、并购或监管处罚等会驱动股价的事实，因此不做交易。
🔎 新鲜度:最早出现 2026-09-01 · 扩散 low · price-in 风险 low ↗
关键理由
- 本事件不改变Haleon收入、利润、现金流或股东回报预期。
- 披露目的为权益申报分母更新，不构成可交易基本面催化。
主要风险
- 若同日另有业绩、回购、并购或重大经营披露，需要作为独立事件重新评估。
先例如何影响了这次决策
对本次决策的影响:未改变结论；直接按事件性质回避。
方向:例行总投票权披露缺乏基本面机制，历史先例不会改变不交易结论。
涨幅量级:无可用于校准的价格幅度，因为当前事件不是经营、资本结构或控制权变化。
形态:不适用。
原文全文
展开原文 · 2,537 字
----- a6350s.htm -----
6-K
1
a6350s.htm
TOTAL VOTING RIGHTS AND CAPITAL
a6350s
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
Form
20-F
☒
Form
40-F
☐
EXHIBIT INDEX
Exhibit
Number
Description
99.1
01
September 2026 -
“Total Voting
Rights and Capital”
99.1
Haleon plc: Total Voting Rights and Capital
01 September 2026:
As
at 31 August 2026 the total number of shares issued by Haleon plc
("Haleon" or the "Company") is 8,808,341,409
ordinary
shares of £0.01 each, of which 11,792,625 are held as treasury
shares.
Therefore, the number of ordinary shares with voting rights is
8,796,548,784 and this figure should be used by shareholders (and
others with notification obligations) as the denominator for the
calculation by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
Notifiable interests in Haleon may be sent to:
company.secretary@haleon.com
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused
on better everyday health. Our people, our brands, our research,
our investment and our innovation are aimed at improving the
everyday health of consumers. Our product portfolio spans six major
categories - Oral Health, Vitamins, Minerals and Supplements (VMS),
Pain Relief, Respiratory Health, Digestive Health and Therapeutic
Skin Health and Other. Our superior brands - such
as
Advil
,
Centrum
,
Otrivin
,
Panadol
,
parodontax
,
Polident
,
Sensodyne
,
Theraflu
and
Voltaren
- are trusted by more than one billion
consumers and are recommended by health professionals around the
world.
For more information, please visit
www.haleon.com
.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
HALEON PLC
(Registrant)
Date:
September 01, 2026
By:
/s/
Amanda Mellor
Name:
Amanda
Mellor
Title:
Company
Secretary
6-K
1
a6350s.htm
TOTAL VOTING RIGHTS AND CAPITAL
a6350s
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
Form
20-F
☒
Form
40-F
☐
EXHIBIT INDEX
Exhibit
Number
Description
99.1
01
September 2026 -
“Total Voting
Rights and Capital”
99.1
Haleon plc: Total Voting Rights and Capital
01 September 2026:
As
at 31 August 2026 the total number of shares issued by Haleon plc
("Haleon" or the "Company") is 8,808,341,409
ordinary
shares of £0.01 each, of which 11,792,625 are held as treasury
shares.
Therefore, the number of ordinary shares with voting rights is
8,796,548,784 and this figure should be used by shareholders (and
others with notification obligations) as the denominator for the
calculation by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
Notifiable interests in Haleon may be sent to:
company.secretary@haleon.com
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused
on better everyday health. Our people, our brands, our research,
our investment and our innovation are aimed at improving the
everyday health of consumers. Our product portfolio spans six major
categories - Oral Health, Vitamins, Minerals and Supplements (VMS),
Pain Relief, Respiratory Health, Digestive Health and Therapeutic
Skin Health and Other. Our superior brands - such
as
Advil
,
Centrum
,
Otrivin
,
Panadol
,
parodontax
,
Polident
,
Sensodyne
,
Theraflu
and
Voltaren
- are trusted by more than one billion
consumers and are recommended by health professionals around the
world.
For more information, please visit
www.haleon.com
.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
HALEON PLC
(Registrant)
Date:
September 01, 2026
By:
/s/
Amanda Mellor
Name:
Amanda
Mellor
Title:
Company
Secretary
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。